Viridian Therapeutics Inc
VRDN
|
$14.59
-3.76%
-3.91%
1.5M
|
Health Care and Social Assistan...
(0.0% 1d) (-22.3% 1m) (-50.8% 1y) (-3.7% 2d) (-3.2% 3d) (-6.6% 7d) (156.54% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 915,778,846
http://www.miragen.com/
Sec Filling | Patents | 27 employees
(US) Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.
treatment antibody
add to watch list Paper trade email alert is off
Press-releases
SHCO INVESTIGATION NOTICE: Kaskela Law LLC Announces Investigation of Soho House & Co. Inc. (NYSE: SHCO) and Encourages Investors to Contact the Firm
Published: 2024-03-29 (Crawled : 13:00) - prnewswire.com
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
house
Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-03-05 (Crawled : 17:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -0.94%
H: 1.8%
C: -4.03%
conference biopharma global therapeutics
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 1.09%
H: 2.57%
C: 0.67%
year therapeutics financial results
Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
Published: 2024-01-18 (Crawled : 09:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -3.59%
H: 0.0%
C: -6.37%
offering therapeutics
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -0.8%
H: 9.79%
C: 8.65%
conference key therapeutics
Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 0.19%
H: 3.53%
C: 2.09%
conference presentation therapeutics
Viridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended Half-Life for Pivotal Development in Thyroid Eye Disease
Published: 2023-12-18 (Crawled : 13:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 1.04%
H: 11.12%
C: 8.39%
vrdn-003 disease positive thyroid eye program therapeutics potential study
Viridian Therapeutics to Participate in 6th Annual Evercore ISI HealthCONx Conference
Published: 2023-11-21 (Crawled : 19:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -0.68%
H: 3.3%
C: -2.36%
conference therapeutics
Viridian Therapeutics to Participate in the Jefferies London Healthcare Conference
Published: 2023-11-08 (Crawled : 15:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 0.54%
H: 0.37%
C: -5.06%
conference therapeutics
Viridian Therapeutics Announces Encore Presentations at the 2023 Annual Meeting of the American Academy of Ophthalmology
Published: 2023-11-03 (Crawled : 22:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 2.98%
H: 9.45%
C: 4.76%
meeting therapeutics
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0000950170-24-007123 | 4 | 2024-01-24 | 2024-01-22 | Buy | P | 476190 | 1839954 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10